PATENTSCOPE will be unavailable a few hours for maintenance reason on Monday 03.02.2020 at 10:00 AM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (EP3384055) THERAPEUTIC TARGETS FOR THE CORRECTION OF THE HUMAN DYSTROPHIN GENE BY GENE EDITING AND METHODS OF USE

Office : European Patent Office
Application Number: 16871452 Application Date: 30.11.2016
Publication Number: 3384055 Publication Date: 10.10.2018
Publication Kind : A4
Designated States: AL, AT, BA, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Prior PCT appl.: Application Number:US2016064285 ; Publication Number: Click to see the data
IPC:
C12Q 1/68
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
CPC:
A61K 48/005
A61K 31/7105
A61K 47/26
A61K 47/549
A61K 48/0016
C12N 15/102
C12N 15/113
C12N 15/80
C12N 15/8509
C12N 2310/20
C12Q 1/68
Applicants: UNIV DUKE
Inventors: GERSBACH CHARLES A
ROBINSON-HAMM JACQUELINE N
Priority Data: 201562260712 30.11.2015 US
2016064285 30.11.2016 US
201662330336 02.05.2016 US
Title: (DE) THERAPEUTISCHE TARGETS ZUR KORREKTUR DES MENSCHLICHEN DYSTROPHINGENS DURCH GEN-EDITING UND VERFAHREN ZUR VERWENDUNG
(EN) THERAPEUTIC TARGETS FOR THE CORRECTION OF THE HUMAN DYSTROPHIN GENE BY GENE EDITING AND METHODS OF USE
(FR) CIBLES THÉRAPEUTIQUES POUR LA CORRECTION DU GÈNE DE LA DYSTROPHINE HUMAINE PAR L'ÉDITION DE GÈNES ET PROCÉDÉS D'UTILISATION
Abstract:
(EN) Disclosed herein are therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use.
(FR) L'invention concerne des cibles thérapeutiques pour la correction du gène de la dystrophine humaine par l'édition de gènes et des procédés d'utilisation.
Also published as:
AU2016362282CA3001623IN201837014278KR1020180081618CN108779466US20180353615
BR112018011133EA201891317WO/2017/095967